Insider Trades154 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Sell | LH | Adam H Schechter | President & CEO | 4,669 | $320.37 | $25.3B | -8.85% | +27.41% | $1.5M | -4.35% | 10b5-1 | Buy Now |
| Aug 4, 2026 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 924 | $306.74 | $25.3B | -8.85% | +27.41% | $283.4K | -11.73% | — | Buy Now |
| Aug 3, 2026 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 2,758 | $260.73 | $25.3B | -8.85% | +27.41% | $719.1K | -1.22% | — | Buy Now |
| Jul 1, 2026 | Sell | LH | Kathryn W Kyle | EVP, Chief Legal Officer | 165 | $285.17 | $25.3B | -8.85% | +27.41% | $47.1K | -1.64% | 10b5-1 | Buy Now |
| Jul 1, 2026 | Sell | LH | Bryan T Vaughn | EVP and President, Diagnostics | 327 | $285.53 | $25.3B | -8.85% | +27.41% | $93.4K | -1.84% | 10b5-1 | Buy Now |
| Jun 8, 2026 | Sell | LH | Kathryn W Kyle | EVP, Chief Legal Officer | 762 | $263.89 | $25.3B | -8.85% | +27.41% | $201.1K | -16.65% | 10b5-1 | Buy Now |
| May 11, 2026 | Sell | LH | Adam H Schechter | President & CEO | 5,903 | $254.50 | $25.3B | -8.85% | +27.41% | $1.5M | -5.22% | 10b5-1 | Buy Now |
| Mar 26, 2026 | Sell | LH | Akinbolade Oyegunwa | EVP, CIO & CTO | 382 | $268.38 | $25.3B | -8.85% | +27.41% | $102.5K | -7.01% | — | Buy Now |
| Mar 26, 2026 | Sell | LH | Kathryn W Kyle | EVP, Chief Legal Officer | 451 | $268.38 | $25.3B | -8.85% | +27.41% | $121.0K | -8.97% | — | Buy Now |
| Mar 26, 2026 | Sell | LH | Bryan T Vaughn | EVP, Diagnostics | 451 | $268.38 | $25.3B | -8.85% | +27.41% | $121.0K | -6.27% | — | Buy Now |
| Mar 26, 2026 | Sell | LH | Megan D. Bailey | EVP, Pres, Central Labs & Intl | 481 | $268.38 | $25.3B | -8.85% | +27.41% | $129.1K | -9.02% | — | Buy Now |
| Mar 26, 2026 | Sell | LH | Jonathan C Meltzer | EVP, Operations | 1,550 | $267.66 | $25.3B | -8.85% | +27.41% | $414.9K | -16.10% | 10b5-1 | Buy Now |
| Mar 26, 2026 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 1,836 | $268.38 | $25.3B | -8.85% | +27.41% | $492.7K | -18.90% | — | Buy Now |
| Mar 26, 2026 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 2,388 | $267.47 | $25.3B | -8.85% | +27.41% | $638.7K | -30.91% | 10b5-1 | Buy Now |
| Mar 26, 2026 | Sell | LH | Der Vaart Sandra D Van | EVP, Corporate Affairs | 2,722 | $268.38 | $25.3B | -8.85% | +27.41% | $730.5K | -30.38% | — | Buy Now |
| Mar 26, 2026 | Sell | LH | Anita Z Graham | EVP, CHRO | 2,879 | $268.38 | $25.3B | -8.85% | +27.41% | $772.7K | -35.70% | — | Buy Now |
| Mar 26, 2026 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 4,905 | $268.38 | $25.3B | -8.85% | +27.41% | $1.3M | -6.39% | — | Buy Now |
| Mar 26, 2026 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 6,068 | $268.38 | $25.3B | -8.85% | +27.41% | $1.6M | -20.28% | — | Buy Now |
| Mar 26, 2026 | Sell | LH | Adam H Schechter | President & CEO | 26,106 | $268.38 | $25.3B | -8.85% | +27.41% | $7.0M | -18.75% | — | Buy Now |
| Mar 3, 2026 | Sell | LH | Adam H Schechter | President & CEO | 8,705 | $279.96 | $25.3B | -8.85% | +27.41% | $2.4M | -9.73% | — | Buy Now |
| Feb 27, 2026 | Sell | LH | Der Vaart Sandra D Van | EVP, Corporate Affairs | 547.54 | $284.91 | $25.3B | -8.85% | +27.41% | $156.0K | -17.51% | — | Buy Now |
| Feb 24, 2026 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 1,500 | $286.31 | $25.3B | -8.85% | +27.41% | $429.5K | -4.75% | — | Buy Now |
| Feb 19, 2026 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 666 | $277.94 | $25.3B | -8.85% | +27.41% | $185.1K | -26.45% | 10b5-1 | Buy Now |
| Feb 11, 2026 | Sell | LH | Kathryn W Kyle | EVP, Chief Legal Officer | 62 | $289.89 | $25.3B | -8.85% | +27.41% | $18.0K | -1.07% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Akinbolade Oyegunwa | EVP, CIO & CTO | 68 | $289.89 | $25.3B | -8.85% | +27.41% | $19.7K | -1.07% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 83 | $289.89 | $25.3B | -8.85% | +27.41% | $24.1K | -1.17% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Bryan T Vaughn | EVP, Diagnostics | 93 | $289.89 | $25.3B | -8.85% | +27.41% | $27.0K | -0.96% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Der Vaart Sandra D Van | EVP, Corporate Affairs | 99 | $289.89 | $25.3B | -8.85% | +27.41% | $28.7K | -2.27% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Anita Z Graham | EVP, CHRO | 109 | $289.89 | $25.3B | -8.85% | +27.41% | $31.6K | -2.75% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Megan D. Bailey | EVP, Pres, Central Labs & Intl | 138 | $289.89 | $25.3B | -8.85% | +27.41% | $40.0K | -1.94% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Jonathan C Meltzer | EVP, Operations | 157 | $290.18 | $25.3B | -8.85% | +27.41% | $45.6K | -1.85% | 10b5-1 | Buy Now |
| Feb 11, 2026 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 206 | $289.89 | $25.3B | -8.85% | +27.41% | $59.7K | -2.23% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 211 | $289.89 | $25.3B | -8.85% | +27.41% | $61.2K | -0.59% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Julia Aijun Wang | Chief Financial Officer, EVP | 245 | $289.89 | $25.3B | -8.85% | +27.41% | $71.0K | -3.49% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 259 | $289.89 | $25.3B | -8.85% | +27.41% | $75.1K | -2.85% | — | Buy Now |
| Feb 11, 2026 | Sell | LH | Adam H Schechter | President & CEO | 6,794 | $285.61 | $25.3B | -8.85% | +27.41% | $1.9M | -3.30% | 10b5-1 | Buy Now |
| Feb 10, 2026 | Sell | LH | Jonathan C Meltzer | EVP, Operations | 91 | $276.79 | $25.3B | -8.85% | +27.41% | $25.2K | -1.19% | 10b5-1 | Buy Now |
| Feb 6, 2026 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 91 | $275.59 | $25.3B | -8.85% | +27.41% | $25.1K | -1.05% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Akinbolade Oyegunwa | EVP, CIO & CTO | 112 | $275.75 | $25.3B | -8.85% | +27.41% | $30.9K | -0.99% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Kathryn W Kyle | EVP, Chief Legal Officer | 122 | $275.60 | $25.3B | -8.85% | +27.41% | $33.6K | -1.22% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Bryan T Vaughn | EVP, Diagnostics | 122 | $275.60 | $25.3B | -8.85% | +27.41% | $33.6K | -0.67% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 172 | $275.72 | $25.3B | -8.85% | +27.41% | $47.4K | -1.30% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Megan D. Bailey | EVP, Pres, Central Labs & Intl | 180 | $275.29 | $25.3B | -8.85% | +27.41% | $49.6K | -0.98% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Der Vaart Sandra D Van | EVP, Corporate Affairs | 194 | $275.67 | $25.3B | -8.85% | +27.41% | $53.5K | -2.15% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Anita Z Graham | EVP, CHRO | 231 | $275.65 | $25.3B | -8.85% | +27.41% | $63.7K | -4.15% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Julia Aijun Wang | Chief Financial Officer, EVP | 254 | $277.20 | $25.3B | -8.85% | +27.41% | $70.4K | -5.15% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Jonathan C Meltzer | EVP, Operations | 261 | $275.63 | $25.3B | -8.85% | +27.41% | $71.9K | -1.93% | 10b5-1 | Buy Now |
| Feb 6, 2026 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 389 | $275.72 | $25.3B | -8.85% | +27.41% | $107.3K | -0.38% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 458 | $275.67 | $25.3B | -8.85% | +27.41% | $126.3K | -1.63% | — | Buy Now |
| Feb 6, 2026 | Sell | LH | Adam H Schechter | President & CEO | 2,667 | $275.58 | $25.3B | -8.85% | +27.41% | $735.0K | -1.21% | — | Buy Now |
| Nov 11, 2025 | Sell | LH | Adam H Schechter | President & CEO | 5,745 | $262.75 | $25.3B | -8.85% | +27.41% | $1.5M | -6.16% | 10b5-1 | Buy Now |
| Nov 3, 2025 | Sell | LH | Akinbolade Oyegunwa | EVP, CIO & CTO | 107 | $257.84 | $25.3B | -8.85% | +27.41% | $27.6K | -1.85% | — | Buy Now |
| Nov 3, 2025 | Sell | LH | Megan D. Bailey | EVP, Pres, Central Labs & Intl | 179 | $257.84 | $25.3B | -8.85% | +27.41% | $46.2K | -2.81% | — | Buy Now |
| Aug 13, 2025 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 7,806 | $201.43 | $25.3B | -8.85% | +27.41% | $1.6M | +0.00% | — | Buy Now |
| Aug 11, 2025 | Sell | LH | Adam H Schechter | President & CEO | 5,643 | $266.78 | $25.3B | -8.85% | +27.41% | $1.5M | -5.70% | 10b5-1 | Buy Now |
| Jul 29, 2025 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 202 | $261.02 | $25.3B | -8.85% | +27.41% | $52.7K | -5.04% | — | Buy Now |
| Jun 3, 2025 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 2,000 | $247.00 | $25.3B | -8.85% | +27.41% | $494.0K | -6.24% | — | Buy Now |
| May 12, 2025 | Sell | LH | Adam H Schechter | President & CEO | 6,105 | $248.73 | $25.3B | -8.85% | +27.41% | $1.5M | -5.81% | 10b5-1 | Buy Now |
| May 1, 2025 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 829 | $242.26 | $25.3B | -8.85% | +27.41% | $200.8K | -28.75% | — | Buy Now |
| May 1, 2025 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 1,900 | $238.36 | $25.3B | -8.85% | +27.41% | $452.9K | -45.85% | — | Buy Now |
| Apr 1, 2025 | Sell | LH | Megan D. Bailey | EVP, Pres, Central Labs & Intl | 1,614 | $232.65 | $25.3B | -8.85% | +27.41% | $375.5K | -11.19% | — | Buy Now |
| Mar 27, 2025 | Sell | LH | Akinbolade Oyegunwa | EVP, CIO & CTO | 198 | $231.67 | $25.3B | -8.85% | +27.41% | $45.9K | -5.41% | — | Buy Now |
| Mar 27, 2025 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 359 | $231.67 | $25.3B | -8.85% | +27.41% | $83.2K | -11.07% | — | Buy Now |
| Mar 27, 2025 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 1,320 | $231.67 | $25.3B | -8.85% | +27.41% | $305.8K | -10.41% | 10b5-1 | Buy Now |
| Mar 27, 2025 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 1,352 | $231.67 | $25.3B | -8.85% | +27.41% | $313.2K | -24.60% | — | Buy Now |
| Mar 27, 2025 | Sell | LH | Lance Berberian | EVP, Special Advisor, Strategy | 1,353 | $231.67 | $25.3B | -8.85% | +27.41% | $313.4K | -6.76% | — | Buy Now |
| Mar 27, 2025 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 2,109 | $231.67 | $25.3B | -8.85% | +27.41% | $488.6K | -6.17% | — | Buy Now |
| Mar 27, 2025 | Sell | LH | Glenn A Eisenberg | Executive Vice President | 3,630 | $231.67 | $25.3B | -8.85% | +27.41% | $841.0K | -8.74% | — | Buy Now |
| Mar 27, 2025 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 4,840 | $231.67 | $25.3B | -8.85% | +27.41% | $1.1M | -27.82% | 10b5-1 | Buy Now |
| Mar 27, 2025 | Sell | LH | Adam H Schechter | President & CEO | 13,584 | $231.67 | $25.3B | -8.85% | +27.41% | $3.1M | -11.45% | — | Buy Now |
| Feb 28, 2025 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 9,242 | $199.48 | $25.3B | -8.85% | +27.41% | $1.8M | -8.60% | 10b5-1 | Buy Now |
| Feb 25, 2025 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 1,314 | $251.30 | $25.3B | -8.85% | +27.41% | $330.2K | -37.71% | — | Buy Now |
| Feb 24, 2025 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 226 | $250.40 | $25.3B | -8.85% | +27.41% | $56.6K | -4.74% | 10b5-1 | Buy Now |
| Feb 11, 2025 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 41 | $245.14 | $25.3B | -8.85% | +27.41% | $10.1K | -0.41% | — | Buy Now |
| Feb 11, 2025 | Sell | LH | Akinbolade Oyegunwa | EVP, CIO & CTO | 42 | $245.14 | $25.3B | -8.85% | +27.41% | $10.3K | -0.43% | — | Buy Now |
| Feb 11, 2025 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 55 | $245.14 | $25.3B | -8.85% | +27.41% | $13.5K | -0.56% | — | Buy Now |
| Feb 11, 2025 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 86 | $245.14 | $25.3B | -8.85% | +27.41% | $21.1K | -0.73% | — | Buy Now |
| Feb 11, 2025 | Sell | LH | Lance Berberian | EVP, Special Advisor, Strategy | 86 | $245.14 | $25.3B | -8.85% | +27.41% | $21.1K | -0.48% | — | Buy Now |
| Feb 11, 2025 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 134 | $245.14 | $25.3B | -8.85% | +27.41% | $32.8K | -0.57% | — | Buy Now |
| Feb 11, 2025 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 136 | $245.14 | $25.3B | -8.85% | +27.41% | $33.3K | -0.30% | — | Buy Now |
| Feb 11, 2025 | Sell | LH | Glenn A Eisenberg | Executive Vice President | 213 | $245.14 | $25.3B | -8.85% | +27.41% | $52.2K | -0.59% | — | Buy Now |
| Feb 11, 2025 | Sell | LH | Adam H Schechter | President & CEO | 7,347 | $244.71 | $25.3B | -8.85% | +27.41% | $1.8M | -2.78% | 10b5-1 | Buy Now |
| Feb 6, 2025 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 92 | $247.00 | $25.3B | -8.85% | +27.41% | $22.7K | -1.61% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Akinbolade Oyegunwa | EVP, CIO & CTO | 113 | $247.08 | $25.3B | -8.85% | +27.41% | $27.9K | -1.20% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 141 | $247.03 | $25.3B | -8.85% | +27.41% | $34.8K | -1.26% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Megan D. Bailey | EVP, Pres, Central Labs & Intl | 177 | $246.85 | $25.3B | -8.85% | +27.41% | $43.7K | -0.86% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Lance Berberian | EVP, Special Advisor, Strategy | 188 | $247.01 | $25.3B | -8.85% | +27.41% | $46.4K | -0.52% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 196 | $247.03 | $25.3B | -8.85% | +27.41% | $48.4K | -2.02% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Anita Z Graham | EVP, CHRO | 237 | $247.00 | $25.3B | -8.85% | +27.41% | $58.5K | -6.08% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Julia Aijun Wang | Chief Financial Officer, EVP | 336 | $247.74 | $25.3B | -8.85% | +27.41% | $83.2K | -12.54% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 394 | $247.06 | $25.3B | -8.85% | +27.41% | $97.3K | -0.42% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 403 | $247.04 | $25.3B | -8.85% | +27.41% | $99.6K | -1.51% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Glenn A Eisenberg | Executive Vice President | 489 | $247.04 | $25.3B | -8.85% | +27.41% | $120.8K | -0.67% | — | Buy Now |
| Feb 6, 2025 | Sell | LH | Adam H Schechter | President & CEO | 2,585 | $246.98 | $25.3B | -8.85% | +27.41% | $638.4K | -1.18% | — | Buy Now |
| Dec 2, 2024 | Sell | LH | Glenn A Eisenberg | Executive Vice President | 23,422 | $226.32 | $25.3B | -8.85% | +27.41% | $5.3M | +0.00% | — | Buy Now |
| Nov 22, 2024 | Buy | LH | Amy B. Summy | EVP, Chief Marketing Officer | 7,686.5 | $202.14 | $25.3B | -8.85% | +27.41% | $1.6M | +2.87% | — | Buy Now |
| Nov 21, 2024 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 1,000 | $239.42 | $25.3B | -8.85% | +27.41% | $239.4K | -27.25% | — | Buy Now |
| Nov 11, 2024 | Sell | LH | Adam H Schechter | President & CEO | 6,189 | $243.47 | $25.3B | -8.85% | +27.41% | $1.5M | -6.61% | 10b5-1 | Buy Now |
| Aug 19, 2024 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 2,000 | $227.05 | $25.3B | -8.85% | +27.41% | $454.1K | -35.27% | — | Buy Now |
| Aug 15, 2024 | Sell | LH | Glenn A Eisenberg | Chief Financial Officer, EVP | 15,000 | $223.99 | $25.3B | -8.85% | +27.41% | $3.4M | -11.54% | — | Buy Now |
| Aug 5, 2024 | Sell | LH | Lance Berberian | EVP, CIO & CTO | 12,093 | $229.10 | $25.3B | -8.85% | +27.41% | $2.8M | -22.48% | — | Buy Now |
| May 14, 2024 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 2,000 | $210.83 | $25.3B | -8.85% | +27.41% | $421.7K | -14.84% | — | Buy Now |
| Apr 30, 2024 | Sell | LH | Glenn A Eisenberg | Chief Financial Officer, EVP | 4,496 | $201.37 | $25.3B | -8.85% | +27.41% | $905.4K | -8.85% | — | Buy Now |
| Apr 29, 2024 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 2,439 | $204.33 | $25.3B | -8.85% | +27.41% | $498.4K | -53.89% | — | Buy Now |
| Apr 15, 2024 | Sell | LH | Glenn A Eisenberg | Chief Financial Officer, EVP | 4,496 | $203.32 | $25.3B | -8.85% | +27.41% | $914.1K | -8.90% | — | Buy Now |
| Apr 1, 2024 | Sell | LH | Megan D. Bailey | EVP, Chief Strategy Officer | 69 | $216.35 | $25.3B | -8.85% | +27.41% | $14.9K | -1.17% | — | Buy Now |
| Apr 1, 2024 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 3,500 | $217.29 | $25.3B | -8.85% | +27.41% | $760.5K | -46.82% | 10b5-1 | Buy Now |
| Apr 1, 2024 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 6,477 | $217.29 | $25.3B | -8.85% | +27.41% | $1.4M | -56.26% | 10b5-1 | Buy Now |
| Mar 27, 2024 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 894 | $216.57 | $25.3B | -8.85% | +27.41% | $193.6K | -14.39% | — | Buy Now |
| Mar 27, 2024 | Sell | LH | Jonathan P. Divincenzo | EVP, Pres, Central Labs & Intl | 952 | $216.57 | $25.3B | -8.85% | +27.41% | $206.2K | -11.36% | — | Buy Now |
| Mar 27, 2024 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 2,162 | $216.57 | $25.3B | -8.85% | +27.41% | $468.2K | -19.74% | — | Buy Now |
| Mar 27, 2024 | Sell | LH | Lance Berberian | EVP, CIO & CTO | 3,299 | $216.57 | $25.3B | -8.85% | +27.41% | $714.5K | -9.87% | — | Buy Now |
| Mar 27, 2024 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 5,061 | $216.57 | $25.3B | -8.85% | +27.41% | $1.1M | -13.80% | — | Buy Now |
| Mar 27, 2024 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 5,079 | $216.57 | $25.3B | -8.85% | +27.41% | $1.1M | -24.59% | — | Buy Now |
| Mar 27, 2024 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 6,158 | $216.67 | $25.3B | -8.85% | +27.41% | $1.3M | -22.66% | 10b5-1 | Buy Now |
| Mar 27, 2024 | Sell | LH | Glenn A Eisenberg | Chief Financial Officer, EVP | 8,805 | $216.57 | $25.3B | -8.85% | +27.41% | $1.9M | -14.84% | — | Buy Now |
| Mar 27, 2024 | Sell | LH | Adam H Schechter | President and CEO | 31,799 | $216.57 | $25.3B | -8.85% | +27.41% | $6.9M | -21.45% | — | Buy Now |
| Mar 7, 2024 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 227 | $218.45 | $25.3B | -8.85% | +27.41% | $49.6K | -5.56% | 10b5-1 | Buy Now |
| Mar 7, 2024 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 7,167 | $188.48 | $25.3B | -8.85% | +27.41% | $1.4M | -16.23% | 10b5-1 | Buy Now |
| Feb 21, 2024 | Sell | LH | Jonathan P. Divincenzo | EVP, Pres, Central Labs & Intl | 500 | $215.49 | $25.3B | -8.85% | +27.41% | $107.7K | -12.82% | — | Buy Now |
| Feb 21, 2024 | Sell | LH | Glenn A Eisenberg | Chief Financial Officer, EVP | 48,558 | $200.82 | $25.3B | -8.85% | +27.41% | $9.8M | -10.29% | — | Buy Now |
| Feb 13, 2024 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 237 | $226.45 | $25.3B | -8.85% | +27.41% | $53.7K | -3.01% | 10b5-1 | Buy Now |
| Feb 12, 2024 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 43 | $227.45 | $25.3B | -8.85% | +27.41% | $9.8K | -0.69% | — | Buy Now |
| Feb 12, 2024 | Sell | LH | Jonathan P. Divincenzo | EVP, Pres, Central Labs & Intl | 59 | $227.45 | $25.3B | -8.85% | +27.41% | $13.4K | -0.66% | — | Buy Now |
| Feb 12, 2024 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 66 | $227.45 | $25.3B | -8.85% | +27.41% | $15.0K | -0.59% | — | Buy Now |
| Feb 12, 2024 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 87 | $227.45 | $25.3B | -8.85% | +27.41% | $19.8K | -0.53% | — | Buy Now |
| Feb 12, 2024 | Sell | LH | Lance Berberian | EVP, CIO & CTO | 87 | $227.45 | $25.3B | -8.85% | +27.41% | $19.8K | -0.26% | — | Buy Now |
| Feb 12, 2024 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 126 | $227.45 | $25.3B | -8.85% | +27.41% | $28.7K | -0.53% | — | Buy Now |
| Feb 12, 2024 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 137 | $227.45 | $25.3B | -8.85% | +27.41% | $31.2K | -0.37% | — | Buy Now |
| Feb 12, 2024 | Sell | LH | Glenn A Eisenberg | Chief Financial Officer, EVP | 215 | $227.45 | $25.3B | -8.85% | +27.41% | $48.9K | -0.27% | — | Buy Now |
| Feb 12, 2024 | Sell | LH | Adam H Schechter | President & CEO | 1,231 | $227.45 | $25.3B | -8.85% | +27.41% | $280.0K | -0.82% | — | Buy Now |
| Feb 8, 2024 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 259 | $222.06 | $25.3B | -8.85% | +27.41% | $57.5K | -3.28% | 10b5-1 | Buy Now |
| Feb 7, 2024 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 46 | $223.71 | $25.3B | -8.85% | +27.41% | $10.3K | -0.40% | — | Buy Now |
| Feb 7, 2024 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 73 | $223.71 | $25.3B | -8.85% | +27.41% | $16.3K | -0.35% | — | Buy Now |
| Feb 7, 2024 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 94 | $223.71 | $25.3B | -8.85% | +27.41% | $21.0K | -0.32% | — | Buy Now |
| Feb 7, 2024 | Sell | LH | Lance Berberian | EVP, CIO & CTO | 94 | $223.71 | $25.3B | -8.85% | +27.41% | $21.0K | -0.20% | — | Buy Now |
| Feb 7, 2024 | Sell | LH | Anita Z Graham | EVP, CHRO | 107 | $223.71 | $25.3B | -8.85% | +27.41% | $23.9K | -1.49% | — | Buy Now |
| Feb 7, 2024 | Sell | LH | Megan D. Bailey | EVP, Chief Strategy Officer | 113 | $223.71 | $25.3B | -8.85% | +27.41% | $25.3K | -0.58% | — | Buy Now |
| Feb 7, 2024 | Sell | LH | Jonathan P. Divincenzo | EVP, Pres, Central Labs & Intl | 119 | $223.71 | $25.3B | -8.85% | +27.41% | $26.6K | -0.45% | — | Buy Now |
| Feb 7, 2024 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 182 | $223.71 | $25.3B | -8.85% | +27.41% | $40.7K | -0.26% | — | Buy Now |
| Feb 7, 2024 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 204 | $223.71 | $25.3B | -8.85% | +27.41% | $45.6K | -0.21% | — | Buy Now |
| Feb 7, 2024 | Sell | LH | Glenn A Eisenberg | Chief Financial Officer, EVP | 236 | $223.71 | $25.3B | -8.85% | +27.41% | $52.8K | -0.19% | — | Buy Now |
| Feb 7, 2024 | Sell | LH | Adam H Schechter | President & CEO | 1,149 | $223.71 | $25.3B | -8.85% | +27.41% | $257.0K | -0.39% | — | Buy Now |
| Feb 2, 2024 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 45 | $221.54 | $25.3B | -8.85% | +27.41% | $10.0K | -0.76% | — | Buy Now |
| Feb 2, 2024 | Sell | LH | Amy B. Summy | EVP, Chief Marketing Officer | 80 | $221.54 | $25.3B | -8.85% | +27.41% | $17.7K | -0.75% | — | Buy Now |
| Feb 2, 2024 | Sell | LH | Jonathan P. Divincenzo | EVP, Pres, Central Labs & Intl | 85 | $221.54 | $25.3B | -8.85% | +27.41% | $18.8K | -1.04% | — | Buy Now |
| Feb 2, 2024 | Sell | LH | Lance Berberian | EVP, CIO & CTO | 89 | $221.54 | $25.3B | -8.85% | +27.41% | $19.7K | -0.27% | — | Buy Now |
| Feb 2, 2024 | Sell | LH | Mark S Schroeder | EVP, Pres Diagnostics & COO | 132 | $221.54 | $25.3B | -8.85% | +27.41% | $29.2K | -0.61% | — | Buy Now |
| Feb 2, 2024 | Sell | LH | Brian J Caveney | EVP, Pres of ED, CMO & CSO | 166 | $221.54 | $25.3B | -8.85% | +27.41% | $36.8K | -0.47% | — | Buy Now |
| Feb 2, 2024 | Sell | LH | Glenn A Eisenberg | Chief Financial Officer, EVP | 228 | $221.54 | $25.3B | -8.85% | +27.41% | $50.5K | -0.29% | — | Buy Now |
| Feb 2, 2024 | Sell | LH | Der Vaart Sandra D Van | EVP, Chief Legal Officer | 264 | $220.83 | $25.3B | -8.85% | +27.41% | $58.3K | -1.12% | 10b5-1 | Buy Now |
| Feb 2, 2024 | Sell | LH | Adam H Schechter | President & CEO | 822 | $221.54 | $25.3B | -8.85% | +27.41% | $182.1K | -0.60% | — | Buy Now |
| Dec 15, 2023 | Sell | LH | Jonathan P. Divincenzo | EVP, Pres, Central Labs & Intl | 19 | $219.50 | $25.3B | -8.85% | +27.41% | $4.2K | -0.23% | — | Buy Now |
| Nov 16, 2023 | Sell | LH | Peter J Wilkinson | SVP, Chief Accounting Officer | 1,384 | $210.71 | $25.3B | -8.85% | +27.41% | $291.6K | -39.87% | — | Buy Now |